BeOne Medicines (ONC) Capital Expenditures Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 46.88% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 8.97% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 16.27% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | -12.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.25% |
| Dec 31, 2025 | 3.30% |
| Sep 30, 2025 | -27.12% |
| Jun 30, 2025 | -26.86% |
| Mar 31, 2025 | 9.96% |
| Dec 31, 2024 | -51.55% |
| Sep 30, 2024 | 25.86% |
| Jun 30, 2024 | 30.03% |
| Mar 31, 2024 | -1.62% |
| Dec 31, 2023 | 73.77% |
| Sep 30, 2023 | -317.93% |
| Jun 30, 2023 | 190.99% |
| Mar 31, 2023 | 43.79% |
| Dec 31, 2022 | 26.22% |
| Sep 30, 2022 | 163.45% |
| Jun 30, 2022 | 52.79% |
| Mar 31, 2022 | 27.40% |
| Dec 31, 2021 | -56.08% |
| Sep 30, 2021 | 19.77% |
| Jun 30, 2021 | 216.13% |
| Mar 31, 2021 | 47.17% |
| Dec 31, 2020 | 75.79% |
| Sep 30, 2020 | -52.70% |
| Jun 30, 2020 | 3.62% |
| Mar 31, 2020 | 113.78% |
| Dec 31, 2019 | 37.57% |
| Sep 30, 2019 | 7.53% |
| Jun 30, 2019 | 37.23% |
| Mar 31, 2019 | 87.66% |
| Dec 31, 2018 | -137.14% |
| Sep 30, 2018 | 176.00% |
| Jun 30, 2018 | 19.14% |
| Mar 31, 2018 | 44.22% |